Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
| Title | A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder. |
|---|---|
| Full Title | A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder. |
| Disease/Condition | Psychiatry - Non Cancer |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Eric Hollander |
| Contact Name | Genoveva Uzunova |
| Contact Email | guzunova@montefiore.org |
| Protocol Number | IRB# 15-02-06-01 |
| Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
| Status | Enrolling |
| Adult Clinical Trial | No |
| Pediatric Clinical Trial | No |
| Adult, Pediatric, Both | Adult |
